- Home
- SRPT vs ATRO Comparison
SRPT vs ATRO Comparison
Compare SRPT & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRPT | ATRO |
|---|---|---|
| Founded | 1980 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | SRPT | ATRO |
|---|---|---|
| Price | $23.85 | $66.57 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 29 | 2 |
| Target Price | $26.23 | ★ $61.50 |
| AVG Volume (30 Days) | ★ 2.8M | 753.1K |
| Earning Date | 02-25-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,413,715,000.00 | $830,601,000.00 |
| Revenue This Year | $13.72 | $9.39 |
| Revenue Next Year | N/A | $11.52 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 47.15 | 6.19 |
| 52 Week Low | $10.42 | $15.56 |
| 52 Week High | $128.75 | $67.54 |
Technical Indicators
Market Signals| Indicator | SRPT | ATRO |
|---|---|---|
| Relative Strength Index (RSI) | 64.06 | 76.37 |
| Support Level | $20.86 | $53.59 |
| Resistance Level | $24.12 | $56.22 |
| Average True Range (ATR) | 0.95 | 2.28 |
| MACD | 0.16 | 1.00 |
| Stochastic Oscillator | 92.22 | 92.53 |
Price Performance
Historical ComparisonAbout SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About ATRO Astronics Corporation
Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.